Progyny (NASDAQ:PGNY) reports Q3 2026 in line with expectations

What happened

Progyny reported Q3 2026 revenue of $341.3 million, up 8.9% from a year earlier and close to analysts’ expectations. Adjusted profit was $0.52 per share, slightly above estimates. The company forecast Q4 revenue of about $354.7 million and full-year adjusted profit of $2.11 per share.

Confirmed

Global impact / market context

Revenue growth shows Progyny continued expanding sales, while its operating margin rose to 10.3% from 6.9% a year earlier, indicating more operating profit from each dollar of revenue. If that improvement continues, it could support earnings; slower sales growth would limit that benefit.

Analyst inference

The reported revenue and Q4 revenue forecast were close to analysts’ estimates, while adjusted profit modestly exceeded estimates. Full-year adjusted profit guidance was also above estimates. This combination points to steady performance rather than a large change in expected sales or earnings.

Analyst inference

What to watch

1. Watch whether Q4 revenue reaches the roughly $354.7 million forecast; a shortfall could signal weaker sales growth and reduce the revenue base available to support earnings. Analyst inference
2. Track sales volumes against the reported 4.6% year-on-year increase, because continued slowing could constrain revenue growth even if revenue per service remains stable. Analyst inference
3. Compare future operating margins with 10.3%, up from 6.9% a year earlier, to see whether the improved share of revenue retained after operating costs persists. Analyst inference

Evidence

• stockstory.org